{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:53:58Z","timestamp":1775562838972,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,25]]},"DOI":"10.7759\/cureus.16624","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T01:51:40Z","timestamp":1627264300000},"source":"Crossref","is-referenced-by-count":20,"title":["SARS-CoV-2 Vaccination-Induced Transverse Myelitis"],"prefix":"10.7759","author":[{"given":"Nayha","family":"Tahir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gowthami","family":"Koorapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonika","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafiz Muhammad","family":"Jeelani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Sherchan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jishna","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryna","family":"Shayuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.59.4.499","article-title":"Proposed diagnostic criteria and nosology of acute transverse myelitis","volume":"59","author":"Transverse Myelitis Consortium Working Group","year":"2002","unstructured":"Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002, 59:499-505. 10.1212\/wnl.59.4.499","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.12.007","article-title":"The epidemiology of transverse myelitis","volume":"9","author":"Bhat A","year":"2010","unstructured":"Bhat A, Naguwa S, Cheema G, Gershwin ME. The epidemiology of transverse myelitis. Autoimmun Rev. 2010, 9:A395-9. 10.1016\/j.autrev.2009.12.007","journal-title":"Autoimmun Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/sc.1996.82","article-title":"Micturition disturbance in acute transverse myelitis","volume":"34","author":"Sakakibara R","year":"1996","unstructured":"Sakakibara R, Hattori T, Yasuda K, Yamanishi T. Micturition disturbance in acute transverse myelitis. Spinal Cord. 1996, 34:481-5. 10.1038\/sc.1996.82","journal-title":"Spinal Cord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2741\/1351","article-title":"Transverse myelitis: pathogenesis, diagnosis and treatment","volume":"9","author":"Krishnan C","year":"2004","unstructured":"Krishnan C, Kaplin AI, Deshpande DM, Pardo CA, Kerr DA. Transverse myelitis: pathogenesis, diagnosis and treatment. Front Biosci. 2004, 9:1483-99. 10.2741\/1351","journal-title":"Front Biosci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/1352458509345906","article-title":"Clinically isolated acute transverse myelitis: prognostic features and incidence","volume":"15","author":"Young J","year":"2009","unstructured":"Young J, Quinn S, Hurrell M, Taylor B. Clinically isolated acute transverse myelitis: prognostic features and incidence. Mult Scler. 2009, 15:1295-302. 10.1177\/1352458509345906","journal-title":"Mult Scler"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/0961203309345730","article-title":"Transverse myelitis and vaccines: a multi-analysis","volume":"18","author":"Agmon-Levin N","year":"2009","unstructured":"Agmon-Levin N, Kivity S, Szyper-Kravitz M, Shoenfeld Y. Transverse myelitis and vaccines: a multi-analysis. Lupus. 2009, 18:1198-204. 10.1177\/0961203309345730","journal-title":"Lupus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.78.1_meetingabstracts.p03.243","article-title":"Meningitis after vaccination in United States, a report from the CDC\/FDA vaccine adverse event reporting system [1990-2010] (P03.243)","volume":"78","author":"Sheikh Z","year":"2012","unstructured":"Sheikh Z, Abukwaik W, Souayah N. Meningitis after vaccination in United States, a report from the CDC\/FDA vaccine adverse event reporting system [1990-2010] (P03.243). Neurology. 2012, 78:P03.243. 10.1212\/wnl.78.1_meetingabstracts.p03.243","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.1999.0346","article-title":"Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?","volume":"14","author":"Shoenfeld Y","year":"2000","unstructured":"Shoenfeld Y, Aron-Maor A.  Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?. J Autoimmun. 2000, 14:1-10. 10.1006\/jaut.1999.0346","journal-title":"J Autoimmun"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.2006.00840.x","article-title":"Evidence for a causal association between oral polio vaccine and transverse myelitis: a case history and review of the Literature","volume":"42","author":"Kelly H","year":"2006","unstructured":"Kelly H. Evidence for a causal association between oral polio vaccine and transverse myelitis: a case history and review of the Literature. J Paediatr Child Health. 2006, 42:155-9. 10.1111\/j.1440-1754.2006.00840.x","journal-title":"J Paediatr Child Health"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26065","article-title":"ANA investigates: neurological complications of COVID-19 vaccines","volume":"89","author":"Goss AL","year":"2021","unstructured":"Goss AL, Samudralwar RD, Das RR, Nath A. ANA investigates: neurological complications of COVID-19 vaccines. Ann Neurol. 2021, 89:856-7. 10.1002\/ana.26065","journal-title":"Ann Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey M","year":"2021","unstructured":"Voysey M, Clemens SA, Madhi SA, et al.. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021, 397:99-111. 10.1016\/S0140-6736(20)32661-1","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32623-4","article-title":"Oxford-AstraZeneca COVID-19 vaccine efficacy","volume":"397","author":"Knoll MD","year":"2021","unstructured":"Knoll MD, Wonodi C. Oxford-AstraZeneca COVID-19 vaccine efficacy. Lancet. 2021, 397:72-4. 10.1016\/S0140-6736(20)32623-4","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.653786","article-title":"Acute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222)","volume":"12","author":"Rom\u00e1n GC","year":"2021","unstructured":"Rom\u00e1n GC, Gracia F, Torres A, Palacios A, Gracia K, Harris D. Acute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222). Front Immunol. 2021, 12:653786. 10.3389\/fimmu.2021.653786","journal-title":"Front Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.2927","article-title":"The Johnson & Johnson vaccine for COVID-19","volume":"325","author":"Livingston EH","year":"2021","unstructured":"Livingston EH, Malani PN, Creech CB. The Johnson &amp; Johnson vaccine for COVID-19. JAMA. 2021, 325:1575. 10.1001\/jama.2021.2927","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.51278","article-title":"Transverse myelitis spectrum disorders","volume":"57","author":"Pandit L","year":"2009","unstructured":"Pandit L. Transverse myelitis spectrum disorders. Neurol India. 2009, 57:126-33. 10.4103\/0028-3886.51278","journal-title":"Neurol India"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-200206000-00019","article-title":"Immunopathogenesis of acute transverse myelitis","volume":"15","author":"Kerr DA","year":"2002","unstructured":"Kerr DA, Ayetey H. Immunopathogenesis of acute transverse myelitis. Curr Opin Neurol. 2002, 15:339-47. 10.1097\/00019052-200206000-00019","journal-title":"Curr Opin Neurol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199912)46:6<878::aid-ana10>3.0.co;2-q","article-title":"A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease","volume":"46","author":"Weinshenker BG","year":"1999","unstructured":"Weinshenker BG, O'Brien PC, Petterson TM, et al.. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol. 1999, 46:878-86. 10.1002\/1531-8249(199912)46:6&lt;878::aid-ana10&gt;3.0.co;2-q","journal-title":"Ann Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/63667-sars-cov-2-vaccination-induced-transverse-myelitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:27:45Z","timestamp":1707506865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/63667-sars-cov-2-vaccination-induced-transverse-myelitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,25]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.16624","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,25]]}}}